VMD — Vietnamese Stock News

1 published articles · VMD.

Vimedimex (VMD) Reprimanded by HoSE for Delayed 2025 Financial Explanations

Vimedimex Pharmaceutical (VMD) faces HoSE reprimand for late disclosure on audited 2025 statements, despite 59.9% profit growth, amid audit qualifications and VND 1,578B in receivables.

2026-04-17

VMD full analysis All stocks All sectors

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-04-19T13:58:20.007319.

Vimedimex (VMD) Reprimanded by HoSE for Delayed 2025 Financial Explanations